Blogs

Abstract The article provides an in-depth overview of Divi's Labs, a prominent global provider of APIs and intermediates in the pharmaceutical and healthcare sectors. Founded by Dr. Murli Divi, the company's journey from refining production processes to becoming a reliable partner for pharmaceutical players is traced. Divi's business segments, including high-quality Generic APIs, Custom Synthesis Manufacturing, and Neutraceuticals, are highlighted, with 90% of revenue coming from export sales, primarily to the US and Europe. What sets Divi's Labs apart is its focus on a limited set of APIs, allowing cost optimization and market dominance. The company's commanding market shares in key products like naproxen and Dextromethorphan, along with potential growth in newer generics, contribute to its special status. Efficient manufacturing processes, scale advantages, and a division for custom synthesis with Big Pharma partnerships enhance Divi's competitive edge.

  About the company: D-Mart is an Indian retail corporation that operates supermarket all over India. The company's focus is on providing high quality products at affordable prices through efficient supply and by minimizing the unnecessary cost. It was founded by Radhakishna Damani in 2002 in Mumbai. Main problems in retail sector: 1) Low margin Business. 2) Companies take a lot of debt without improving their unit economics. 3) High competition. 4) High leasing cost.  D-Mart business model                                                                                                                                                                                                                                          Image Source:SOIC D-Mart offer products at lower prices because of their business strategies and efficient business model.  This leads to more customers.          This leads to higher inventory turnover (it means that in how many days it  takes a on average, to sell